CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Virmani, A. K.
Right arrow Articles by Laird-Offringa, I. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Virmani, A. K.
Right arrow Articles by Laird-Offringa, I. A.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 291-297, March 2002
© 2002 American Association for Cancer Research

Hierarchical Clustering of Lung Cancer Cell Lines Using DNA Methylation Markers1

Arvind K. Virmani, Jeffrey A. Tsou, Kimberly D. Siegmund, Linda Y. C. Shen, Tiffany I. Long, Peter W. Laird, Adi F. Gazdar and Ite A. Laird-Offringa2

Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9593 [A. K. V., A. F. G.], and Norris Cancer Center and Departments of Surgery and Biochemistry & Molecular Biology [J. A. T., L. Y. C. S., T. I. L., P. W. L., I. A. L-O.], Preventive Medicine [K. D. S.], and Medicine [L. Y. C. S.], Keck School of Medicine, University of Southern California, Los Angeles, California 90089-9176

Recent analyses of global and gene-specific methylation patterns in cancer cells have suggested that cancers from different organs demonstrate distinct patterns of CpG island hypermethylation. Although certain CpG islands are frequently methylated in many different kinds of cancer, others are methylated only in specific tumor types. Because distinct patterns of CpG island hypermethylation can be seen in tumors from different organs, it seems likely that histological subtypes of cancer within a given organ may exhibit distinct methylation patterns as well. The goal of our study was to determine whether the patterns of CpG island hypermethylation could be used to distinguish between different histological subtypes of lung cancer. We analyzed the methylation status of 23 loci in 91 lung cancer cell lines using the quantitative real-time PCR method MethyLight. Genes PTGS2 (COX2), CALCA, MTHFR, ESR1, MGMT, MYOD1, and APC showed statistically significant differences in the level of CpG island methylation between small cell lung cancer (SCLC) and non-small cell lung cancer cell lines (NSCLC). Hierarchical clustering using a panel consisting of these seven loci yielded two major groups, one of which contained 78% of the SCLC lines. Within this group, a large cluster consisted almost exclusively of SCLC cell lines. Our results show that DNA methylation patterns differ between NSCLC and SCLC cell lines and suggest that these patterns could be developed into a powerful molecular marker to achieve accurate diagnosis of lung cancer.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
T. K. Wojdacz and A. Dobrovic
Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation
Nucleic Acids Res., March 19, 2007; 35(6): e41 - e41.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Wang, H. Liu, Z. Zhang, M. R. Spitz, and Q. Wei
Association of Genetic Variants of O6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2364 - 2369.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. O. Hoque, Q. Feng, P. Toure, A. Dem, C. W. Critchlow, S. E. Hawes, T. Wood, C. Jeronimo, E. Rosenbaum, J. Stern, et al.
Detection of Aberrant Methylation of Four Genes in Plasma DNA for the Detection of Breast Cancer
J. Clin. Oncol., September 10, 2006; 24(26): 4262 - 4269.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B. R. Vuillemenot, J. A. Hutt, and S. A. Belinsky
Gene Promoter Hypermethylation in Mouse Lung Tumors
Mol. Cancer Res., April 1, 2006; 4(4): 267 - 273.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. D. Siegmund, A. J. Levine, J. Chang, and P. W. Laird
Modeling exposures for DNA methylation profiles.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 567 - 572.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky
Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects
J. Clin. Oncol., September 20, 2005; 23(27): 6569 - 6575.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
U. Lehmann, I. Berg-Ribbe, L. U. Wingen, K. Brakensiek, T. Becker, J. Klempnauer, B. Schlegelberger, H. Kreipe, and P. Flemming
Distinct Methylation Patterns of Benign and Malignant Liver Tumors Revealed by Quantitative Methylation Profiling
Clin. Cancer Res., May 15, 2005; 11(10): 3654 - 3660.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Jeronimo, R. Henrique, M. O. Hoque, E. Mambo, F. R. Ribeiro, G. Varzim, J. Oliveira, M. R. Teixeira, C. Lopes, and D. Sidransky
A Quantitative Promoter Methylation Profile of Prostate Cancer
Clin. Cancer Res., December 15, 2004; 10(24): 8472 - 8478.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. M. Muller, S. Millinger, H. Fiegl, G. Goebel, L. Ivarsson, A. Widschwendter, E. Muller-Holzner, C. Marth, and M. Widschwendter
Analysis of Methylated Genes in Peritoneal Fluids of Ovarian Cancer Patients: A New Prognostic Tool
Clin. Chem., November 1, 2004; 50(11): 2171 - 2173.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. L. Gonzalgo, S. Yegnasubramanian, G. Yan, C. G. Rogers, T. L. Nicol, W. G. Nelson, and C. P. Pavlovich
Molecular Profiling and Classification of Sporadic Renal Cell Carcinoma by Quantitative Methylation Analysis
Clin. Cancer Res., November 1, 2004; 10(21): 7276 - 7283.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. F. Gazdar, K. Miyajima, J. Reddy, U. G. Sathyanarayana, H. Shigematsu, M. Suzuki, T. Takahashi, and N. Shivapurkar
Molecular Targets for Cancer Therapy and Prevention
Chest, May 1, 2004; 125(5_suppl): 97S - 101S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y.-I. Kim
Folate and DNA Methylation: A Mechanistic Link between Folate Deficiency and Colorectal Cancer?
Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 511 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
A. M. Marchevsky, J. A. Tsou, and I. A. Laird-Offringa
Classification of Individual Lung Cancer Cell Lines Based on DNA Methylation Markers: Use of Linear Discriminant Analysis and Artificial Neural Networks
J. Mol. Diagn., February 1, 2004; 6(1): 28 - 36.
[Abstract] [Full Text]


Home page
Ann. N. Y. Acad. Sci.Home page
D. J. SMIRAGLIA and C. PLASS
The Development of CpG Island Methylation Biomarkers Using Restriction Landmark Genomic Scanning
Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 110 - 119.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. VERMA
Viral Genes and Methylation
Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 170 - 180.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. VERMA, B. K. DUNN, S. ROSS, P. JAIN, W. WANG, R. HAYES, and A. UMAR
Early Detection and Risk Assessment Proceedings and Recommendations from the Workshop on Epigenetics in Cancer Prevention
Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 298 - 319.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. F. Paz, M. F. Fraga, S. Avila, M. Guo, M. Pollan, J. G. Herman, and M. Esteller
A Systematic Profile of DNA Methylation in Human Cancer Cell Lines
Cancer Res., March 1, 2003; 63(5): 1114 - 1121.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K.-J. Sohn, J. M. Stempak, S. Reid, S. Shirwadkar, J. B. Mason, and Y.-I. Kim
The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon
Carcinogenesis, January 1, 2003; 24(1): 81 - 90.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.